Epidemiology

You have full text access to this OnlineOpen article

Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico

  1. Salvatore Vaccarella1,
  2. Eduardo Lazcano-Ponce2,†,*,
  3. José Antonio Castro-Garduño3,
  4. Aurelio Cruz-Valdez2,
  5. Vicente Díaz4,
  6. Rafaela Schiavon3,
  7. Pilar Hernández2,
  8. Janet R. Kornegay5,
  9. Mauricio Hernández-Avila2,
  10. Silvia Franceschi1

Article first published online: 17 MAY 2006

DOI: 10.1002/ijc.21992

Issue

International Journal of Cancer

International Journal of Cancer

Volume 119, Issue 8, pages 1934–1939, 15 October 2006

Additional Information

How to Cite

Vaccarella, S., Lazcano-Ponce, E., Castro-Garduño, J. A., Cruz-Valdez, A., Díaz, V., Schiavon, R., Hernández, P., Kornegay, J. R., Hernández-Avila, M. and Franceschi, S. (2006), Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico. Int. J. Cancer, 119: 1934–1939. doi: 10.1002/ijc.21992

Author Information

  1. 1

    International Agency for Research on Cancer, Lyon, France

  2. 2

    Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico

  3. 3

    Dirección General de Equidad y Género en Salud, Dirección de Salud Reproductiva, Mexico City, Mexico

  4. 4

    Fundación Mexicana para la Planeación Familiar, Mexico City, Mexico

  5. 5

    Roche Molecular Systems, Inc., Alameda, CA

  1. †

    Fax: +52-777-311-11-48.

*Centro de Investigaciones en Salud Poblacional, Instituto Nacional de Salud Pública, Av. Universidad 655, Col. Sta Maria, Ahuacatitlan, C.P. 62508 Cuernavaca, Morelos, Mexico

Publication History

  1. Issue published online: 11 AUG 2006
  2. Article first published online: 17 MAY 2006
  3. Manuscript Accepted: 1 MAR 2006
  4. Manuscript Received: 13 JAN 2006

Funded by

  • Mexican National Science and Technology Council (Consejo Nacional de Ciencia y Tecnología, CONACYT). Grant Numbers: SALUD-2002-C01-7800, 34468-M
  • International Agency for Research on Cancer. Grant Numbers: FI/92/3-5 MEX-4, FIS/03/02
  • Instituto Nacional de Salud Pública

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (121K)

References

  • 1
    Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12–19.
    Direct Link:
  • 2
    Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJF, Vaccarella S, Anh PTH, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366: 991–8.
  • 3
    von Krogh G. Management of anogenital warts (condylomata acuminata). Eur J Dermatol 2001; 11: 598–603.
  • 4
    Bleeker MC, Hogewoning CJ, Berkhof J, Voorhorst FJ, Hesselink AT, van Diemen PM, van den Brule AJ, Snijders PJF, Meijer CJLM. Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads. Clin Infect Dis 2005; 41: 612–20.
  • 5
    Baken LA, Koutsky LA, Kuypers J, Kosorok MR, Lee SK, Kiviat NB, Holmes KK. Genital human papillomavirus infection among male and female sex partners: prevalence and type-specific concordance. J Infect Dis 1995; 171: 429–32.
  • 6
    Bosch FX, Castellsagué X, Muñoz N, de Sanjosé S, Ghaffari AM, Gonzalez LC, Gili M, Izarzugaza I, Viladiu P, Navarro C, Vergara A, Ascunce N, et al. Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst 1996; 88: 1060–7.
  • 7
    Castellsagué X, Ghaffari A, Daniel RW, Bosch FX, Muñoz N, Shah KV. Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J Infect Dis 1997; 176: 353–61.
  • 8
    Franceschi S, Castellsagué X, Dal Maso L, Smith JS, Plummer M, Ngelangel C, Chichareon S, Eluf-Neto J, Shah KV, Snijders PJF, Meijer CJLM, Bosch FX, et al. Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer 2002; 86: 705–11.
  • 9
    Svare EI, Kjaer SK, Worm AM, Osterlind A, Meijer CJLM, van den Brule AJ. Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect 2002; 78: 215–18.
  • 10
    Castellsagué X, Bosch FX, Muñoz N, Meijer CJLM, Shah KV, de Sanjosé S, Eluf-Neto J, Ngelangel CA, Chichareon S, Smith JS, Herrero R, Moreno V, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002; 346: 1105–12.
  • 11
    IARC. Human papillomavirus. Monographs on the evaluation of carcinogenic risks to humans, vol. 64. Lyon: International Agency for Research on Cancer, 1995.
  • 12
    Lazcano-Ponce E, Herrero R, Muñoz N, Hernandez-Avila M, Salmeron J, Leyva A, Meijer CJLM, Walboomers JM. High prevalence of human papillomavirus infection in Mexican males: comparative study of penile-urethral swabs and urine samples. Sex Transm Dis 2001; 28: 277–80.
  • 13
    Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, Vaught LC, Kornegay JR, Hallum JA, Redmond SA, Giuliano AR. Human papillomavirus infection in men attending a sexually transmitted disease clinic. J Infect Dis 2003; 187: 1064–70.
  • 14
    Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, Vaught LC, Giuliano AR. Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic. Sex Transm Dis 2004; 31: 601–7.
  • 15
    Hippelainen M, Syrjanen S, Hippelainen M, Koskela H, Pulkkinen J, Saarikoski S, Syrjanen K. Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts. Sex Transm Dis 1993; 20: 321–8.
  • 16
    Kjaer SK, Munk C, Winther JF, Jorgensen HO, Meijer CJLM, van den Brule AJ. Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers. Cancer Epidemiol Biomarkers Prev 2005; 14: 1528–33.
  • 17
    Lajous M, Mueller N, Cruz-Valdez A, Aguilar LV, Franceschi S, Hernandez-Avila M, Lazcano-Ponce E. Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev 2005; 14: 1710–16.
  • 18
    Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998; 36: 3020–7.
  • 19
    Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38: 357–61.
  • 20
    Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJF, Meijer CJLM. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518–27.
  • 21
    ParkinDM, WhelanSL, FerlayJ, ThomasDB, TeppoL, eds. Cancer incidence in five continents, vol. VIII. Lyon: IARC, 2002. IARC Scientific Publications No: 155.
  • 22
    Lazcano-Ponce E, Herrero R, Muñoz N, Cruz A, Shah KV, Alonso P, Hernandez P, Salmeron J, Hernandez M. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001; 91: 412–20.
    Direct Link:
  • 23
    Juarez-Figueroa LA, Wheeler CM, Uribe-Salas FJ, Conde-Glez CJ, Zampilpa-Mejia LG, Garcia-Cisneros S, Hernandez-Avila M. Human papillomavirus: a highly prevalent sexually transmitted disease agent among female sex workers from Mexico City. Sex Transm Dis 2001; 28: 125–30.
  • 24
    Muñoz N, Castellsagué X, Bosch FX, Tafur L, de Sanjosé S, Aristizabal N, Ghaffari AM, Shah KV. Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease. J Natl Cancer Inst 1996; 88: 1068–75.
  • 25
    Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 2002; 29: 725–35.
  • 26
    Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005; 191: 1796–807.
  • 27
    Vaccarella S, Franceschi S, Herrero R, Muñoz N, Snijders PJF, Clifford GM, Smith JS, Lazcano-Ponce E, Sukvirach S, Shin HR, de Sanjosé S, Molano M et al. Sexual behaviour, condom use and HPV: pooled analysis of the International Agency for Research on Cancer HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev 2006; 15: 326–33.
  • 28
    Bleeker MC, Berkhof J, Hogewoning CJ, Voorhorst FJ, van den Brule AJ, Starink TM, Snijders PJF, Meijer CJLM. HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions. Br J Cancer 2005; 92: 1388–92.
  • 29
    Coutlee F, de Ladurantaye M, Tremblay C, Vincelette J, Labrecque L, Roger M. An important proportion of genital samples submitted for Chlamydia trachomatis detection by PCR contain small amounts of cellular DNA as measured by β-globin gene amplification. J Clin Microbiol 2000; 38: 2512–15.
  • 30
    Aguilar LV, Lazcano-Ponce E, Vaccarella S, Cruz A, Hernández P, Smith JS, Muñoz N, Kornegay JR, Hernández-Avila M, Franceschi S. Human papillomavirus in men: comparison of different genital sites. Sex Transm Infect 2006; 82: 31–3.
  • 31
    Jezowski TW, Alarcón F, Juárez C, Estrada A, Gómez F. A successful national program for expanding vasectomy services: the experience of the Instituto Mexicano del Seguro Social. AVSC Working Paper No. 8. June 1995. Available at: www.engenderhealth.org/pubs/workpap/wp8/wp_8.html
View Full Article (HTML) Get PDF (121K)